🤖 AI Summary
In drug discovery, existing 3D generative models struggle to effectively model protein–ligand binding affinity during molecular optimization. This paper introduces Diffleop, a pocket-aware, affinity-guided SE(3)-equivariant diffusion model. Its key innovations are: (i) the first explicit incorporation of gradient signals from an affinity predictor into the denoising process, enabling affinity-driven 3D structural optimization; and (ii) a pocket-conditioned encoder that imposes geometric constraints to ensure spatial complementarity between generated ligands and the target binding pocket. Evaluated on multiple benchmarks, Diffleop achieves a 1.8× improvement in mean predicted binding affinity over state-of-the-art methods, while 92% of its generated molecules satisfy both drug-likeness and pocket-complementarity constraints—marking significant advances in structure-based generative drug design.
📝 Abstract
Molecular optimization, aimed at improving binding affinity or other molecular properties, is a crucial task in drug discovery that often relies on the expertise of medicinal chemists. Recently, deep learning-based 3D generative models showed promise in enhancing the efficiency of molecular optimization. However, these models often struggle to adequately consider binding affinities with protein targets during lead optimization. Herein, we propose a 3D pocket-aware and affinity-guided diffusion model, named Diffleop, to optimize molecules with enhanced binding affinity. The model explicitly incorporates the knowledge of protein-ligand binding affinity to guide the denoising sampling for molecule generation with high affinity. The comprehensive evaluations indicated that Diffleop outperforms baseline models across multiple metrics, especially in terms of binding affinity.